1. Home
  2. PDLB vs MOLN Comparison

PDLB vs MOLN Comparison

Compare PDLB & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDLB
  • MOLN
  • Stock Information
  • Founded
  • PDLB 1960
  • MOLN 2004
  • Country
  • PDLB United States
  • MOLN Switzerland
  • Employees
  • PDLB N/A
  • MOLN N/A
  • Industry
  • PDLB
  • MOLN
  • Sector
  • PDLB
  • MOLN
  • Exchange
  • PDLB Nasdaq
  • MOLN Nasdaq
  • Market Cap
  • PDLB 262.0M
  • MOLN 284.7M
  • IPO Year
  • PDLB 2017
  • MOLN 2021
  • Fundamental
  • Price
  • PDLB $11.94
  • MOLN $4.98
  • Analyst Decision
  • PDLB
  • MOLN Hold
  • Analyst Count
  • PDLB 0
  • MOLN 1
  • Target Price
  • PDLB N/A
  • MOLN $4.50
  • AVG Volume (30 Days)
  • PDLB 55.1K
  • MOLN 8.5K
  • Earning Date
  • PDLB 10-28-2024
  • MOLN 08-26-2024
  • Dividend Yield
  • PDLB N/A
  • MOLN N/A
  • EPS Growth
  • PDLB N/A
  • MOLN N/A
  • EPS
  • PDLB 0.39
  • MOLN N/A
  • Revenue
  • PDLB $81,737,000.00
  • MOLN $8,749,165.00
  • Revenue This Year
  • PDLB N/A
  • MOLN $8.70
  • Revenue Next Year
  • PDLB $7.70
  • MOLN N/A
  • P/E Ratio
  • PDLB $30.73
  • MOLN N/A
  • Revenue Growth
  • PDLB 70.84
  • MOLN N/A
  • 52 Week Low
  • PDLB $7.34
  • MOLN $3.32
  • 52 Week High
  • PDLB $11.99
  • MOLN $12.70
  • Technical
  • Relative Strength Index (RSI)
  • PDLB 64.70
  • MOLN 48.33
  • Support Level
  • PDLB $10.88
  • MOLN $4.70
  • Resistance Level
  • PDLB $11.99
  • MOLN $4.97
  • Average True Range (ATR)
  • PDLB 0.23
  • MOLN 0.34
  • MACD
  • PDLB 0.03
  • MOLN 0.07
  • Stochastic Oscillator
  • PDLB 95.50
  • MOLN 62.24

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: